Loading…
Jasper Therapeutics, Inc. is projected to rise to $0.6561 by 2027, a +8% move from its current price of $0.6063. JSPR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.5681 | $0.6065 | $0.6476 | +0.04% |
| Aug 6 | $0.5531 | $0.6068 | $0.6656 | +0.08% |
| Aug 7 | $0.5419 | $0.607 | $0.6799 | +0.11% |
| Aug 8 | $0.5327 | $0.6072 | $0.6921 | +0.15% |
| Aug 9 | $0.5247 | $0.6074 | $0.7032 | +0.19% |
| Aug 10 | $0.5176 | $0.6077 | $0.7133 | +0.23% |
| Aug 11 | $0.5112 | $0.6079 | $0.7228 | +0.26% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.5112 | $0.6079 | $0.7228 | +0.26% |
| Week 2 | $0.4771 | $0.6095 | $0.7786 | +0.53% |
| Week 3 | $0.4527 | $0.6111 | $0.8249 | +0.79% |
| Week 4 | $0.4333 | $0.6127 | $0.8663 | +1.06% |
| Week 5 | $0.4171 | $0.6143 | $0.9048 | +1.32% |
| Week 6 | $0.403 | $0.6159 | $0.9414 | +1.59% |
| Week 7 | $0.3906 | $0.6176 | $0.9765 | +1.86% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company focusing on developing therapeutics targeting mast stem cell driven diseases in the United States. The lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factors from binding to and signaling through the CD117 receptor on mast and stem cells.
The company concentrates on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma.
Jasper Therapeutics, Inc. was founded in 2018 and is headquartered in Redwood City, California.
Jasper Therapeutics, Inc. (JSPR) is the asset. Current price is $0.633, market capitalization is $21.06M, and its rank is 4646.
The stock is trading near the SMA50 of $0.6224 and well below the SMA200 of $1.30, indicating the near-term price context relative to its longer-term trend.
In the last 30 days, the 30-day range runs from $0.3984 to $1.01, with a defined support at $0.341 and resistance at $0.885. Annualized volatility stands at 100%.
Forecast data show a mixed near-term outlook with a neutral sentiment in 2026 (avg $0.633) and a sequence of longer-term moves: a bearish turn in 2030 (avg $0.5207, ROI -17.7%), followed by bullish momentum in 2032-2035 and a strong uptrend into 2040 ($1.29 avg, ROI 103.8%) and 2050 ($1.66 avg, ROI 162%).
A major floor 87.7% below — a decisive break under it would weaken the trend.
The nearest floor, 43.8% below — buyers have tended to step in here.
The nearest ceiling, 46.0% above — a clean break opens room to run.
A major ceiling 91.8% above — clearing it would confirm fresh momentum.
Key JSPR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of JSPR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.6356 | Sell | $0.6413 | Sell |
| MA 10 | $0.6924 | Sell | $0.6604 | Sell |
| MA 20 | $0.6615 | Sell | $0.6485 | Sell |
| MA 50 | $0.6034 | Buy | $0.6683 | Sell |
| MA 100 | $0.7926 | Sell | $0.8565 | Sell |
| MA 200 | $1.26 | Sell | $1.69 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.86 | Neutral |
| Stoch RSI (14) | 10.44 | Buy |
| CCI (20) | -23.36 | Neutral |
| Williams %R (14) | -89.47 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -8.96 | Sell |
| Bollinger %B (20,2) | 0.43 | Neutral |
| Stochastic %K (14) | 10.53 | Buy |
| TRIX (15) | 0.92 | Buy |
| Awesome (5,34) | 0.06 | Buy |
| Ultimate (7,14,28) | 33.69 | Neutral |
| Momentum (10) | -0.25 | Sell |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 0.59 | Buy |
| ADX (14) | 18.59 | Neutral |
| ATR (14) | 0.04 | Info |
RSI(14) is 50, indicating neutral momentum, while the technical sentiment is BULLISH. The stock’s 50-day simple moving average is $0.6224 and the 200-day simple moving average is $1.30, framing the current trend against a longer horizon.
The 30-day trading range spans from $0.3984 to $1.01, with a defined support at $0.341 and resistance at $0.885, outlining near-term price boundaries for potential moves.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.341 | $0.6063 | $0.8085 | 0% | Neutral | |
| $0.4781 | $0.6561 | $0.9731 | +8% | Neutral | |
| $0.3881 | $0.5664 | $0.8963 | -7% | Neutral | |
| $0.3811 | $0.5862 | $0.9746 | -3% | Neutral | |
| $0.3109 | $0.5015 | $0.8682 | -17% | Bearish | |
| $0.2904 | $0.4896 | $0.8778 | -19% | Bearish | |
| $0.4177 | $0.7347 | $1.36 | +21% | Bullish | |
| $0.4381 | $0.8024 | $1.53 | +32% | Bullish | |
| $0.4165 | $0.7936 | $1.55 | +31% | Bullish | |
| $0.4147 | $0.8215 | $1.64 | +35% | Bullish | |
| $0.5429 | $1.21 | $2.65 | +99% | Bullish | |
| $0.6941 | $1.54 | $3.55 | +154% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.341 | $0.6063 | $0.7649 | +0.00% |
| September 2026 | $0.5339 | $0.649 | $0.823 | +7.04% |
| October 2026 | $0.509 | $0.6274 | $0.8119 | -3.32% |
| November 2026 | $0.4741 | $0.591 | $0.7772 | -5.80% |
| December 2026 | $0.481 | $0.606 | $0.8085 | +2.54% |
Click any year to see its month-by-month JSPR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The JSPR price prediction for 2026 points to an average of $0.6063 (low $0.341, high $0.8085) — a potential gain of 0% on today's $0.6063. Price action looks broadly range-bound.
In 2027, JSPR is projected to trade between $0.4781 and $0.9731, averaging $0.6561 — a potential gain of +8% from today's $0.6063. That is up +8% on the projected 2026 average. A consolidation phase looks the most probable path here.
Jasper Therapeutics, Inc.'s 2028 outlook centres on $0.5664, within a $0.3881 to $0.8963 range. That is -14% versus the projected 2027 average. That marks a -7% change versus current levels. Price action looks broadly range-bound.
By 2029, JSPR could reach as high as $0.9746, with a base case around $0.5862 and support toward $0.3811 — roughly -3% from $0.6063. A consolidation phase looks the most probable path here.
Expect JSPR to range from $0.3109 to $0.8682 through 2030. The $0.5015 average target implies a -17% move from current prices. That is -14% versus the projected 2029 average. A cyclical pullback looks likely — prices rarely move in a straight line.
The JSPR price prediction for 2031 points to an average of $0.4896 (low $0.2904, high $0.8778) — a potential decline of -19% on today's $0.6063. Expect choppier, lower action through this leg of the cycle.
In 2032, JSPR is projected to trade between $0.4177 and $1.36, averaging $0.7347 — a potential gain of +21% from today's $0.6063. That is up +50% on the projected 2031 average. Momentum favours further upside here.
Jasper Therapeutics, Inc.'s 2033 outlook centres on $0.8024, within a $0.4381 to $1.53 range. That is up +9% on the projected 2032 average. That marks a +32% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, JSPR could reach as high as $1.55, with a base case around $0.7936 and support toward $0.4165 — roughly +31% from $0.6063. Momentum favours further upside here.
Expect JSPR to range from $0.4147 to $1.64 through 2035. The $0.8215 average target implies a +35% move from current prices. That is up +4% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The JSPR price prediction for 2040 points to an average of $1.21 (low $0.5429, high $2.65) — a potential gain of +99% on today's $0.6063. Momentum favours further upside here.
In 2050, JSPR is projected to trade between $0.6941 and $3.55, averaging $1.54 — a potential gain of +154% from today's $0.6063. That is up +28% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in JSPR today (≈ 1,649.348507 JSPR) could be worth
$2,543.98
+$1,543.98 (+154%) by 2050 · US Dollar
Based on the average projected JSPR price of $1.54 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in JSPRwould be worth at today's price.
$1,000 invested in JSPR on Jul 31, 2025 (≈ 344.827575 JSPR) would be worth
$209.07
-$790.93 (-79.1%) today · 0.21× · US Dollar
Based on a JSPR entry price of $2.9 vs. today's $0.6063.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.688 | $881.25 | -11.9% |
| 1 month ago | $0.455 | $1,332.53 | +33.3% |
| 3 months ago | $0.93 | $651.94 | -34.8% |
| 6 months ago | $1.47 | $412.45 | -58.8% |
| 1 year ago | $2.9 | $209.07 | -79.1% |
| All time (5.0y) ago | $99.12 | $6.12 | -99.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our JSPR forecast.
Our base-case forecast reaches $1.20 around 2040.
Implied market cap at $1.20: $39.93M
The multi-year forecast shows a path that begins with a neutral near-term stance and evolves into mixed intermediate signals before turning decisively bullish later in the decade. In 2030, the average price is projected at $0.5207 with a -17.7% ROI and a bearish sentiment, followed by further weakness in 2031 (avg $0.5191, ROI -18%, bearish). Beginning in 2032, the forecast turns bullish with an average around $0.7957 and rising through 2035 (avg $0.8836, ROI 39.6%) and beyond.
Looking to 2040, the average price is projected at $1.29 with a 103.8% ROI and a bullish sentiment, and in 2050 the average is $1.66 with a 162% ROI, still bullish. These figures illustrate substantial upside potential in the long run, but they come with substantial volatility and year-to-year variability.
Overall, the outlook suggests the asset could experience meaningful upside in the long term while carrying notable downside risk in the near to mid term. These are estimates, not guarantees, and should be weighed against individual risk tolerance and investment objectives.
Tap a question to reveal the answer.
2030 forecast: min $0.3226, avg $0.5207, max $0.9022, ROI -17.7%, sentiment BEARISH.
Near-term forecasts show neutral momentum in 2026 (avg $0.633, ROI 0, sentiment NEUTRAL) with occasional downside in 2030 (-17.7% ROI, bearish) but long-term potential appears bullish in 2040 (avg $1.29, ROI 103.8%, bullish) and 2050 (avg $1.66, ROI 162%, bullish). These are estimates and involve volatility and risk.
Yes, based on the max forecast values: 2040 max $2.83 and 2050 max $3.81, with earlier years showing maxs such as 2032 $1.47, 2033 $1.60, 2034 $1.63, and 2035 $1.76.
Current price: $0.633. Market capitalization: $21.06M.
30-day range: low $0.3984, high $1.01. Support at $0.341 and resistance at $0.885.
Jasper Therapeutics, Inc. Community Discussion
0Share your Jasper Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.